Thema: US09062X1037
Biogen Inc., US09062X1037
Biogen Inc. Pop-Art-Comic zeigt Wissenschaftler-Held der triumphierend eine Alzheimer-Therapie entdeckt ISIN US09062X1037 - Foto: THN
Biogen stock trades at 227 euros in Friday evening session
Biogen stock remained in focus during Friday's evening session. The listed biotechnology company is identified by ISIN US09062X1037.
ad-hoc-news.de, heute 19:37 Uhr
Biogen Inc., US09062X1037
Biogen schedules October 28 results. Biogen stock trades ...
Q2 revenue reached USD 2.736 billion. Biogen stock costs EUR 226.70 on October 27, 2026, while USD 252.83 is 0.62 percent below USD 254.41.
ad-hoc-news.de, 27.10.26 19:24 Uhr
Biogen Inc., US09062X1037
BofA raises target for Biogen stock to USD 244.00
Growth products reached USD 1.06 billion in Q2 2026 up 24.00 percent year over year. Biogen stock costs EUR 223.78 on October 24 2026 down 0.54 percent versus the Tradegate ...
ad-hoc-news.de, 24.10.26 21:10 Uhr
Biogen Inc., US09062X1037
Biogen stock: TD Cowen raises target to USD 250 for Biogen ...
TD Cowen models USD 1.99 adjusted earnings per share for third quarter. Biogen stock costs EUR 226.28 on October 22, 2026 at 10:15 p.m. CEST.
ad-hoc-news.de, 22.10.26 22:18 Uhr
Biogen Inc., US09062X1037
JPMorgan raises Biogen stock target to USD 300.00 without ...
Biogen stock has results due October 28, 2026 before the open. It costs EUR 217.10 at Lang & Schwarz on October 20, 2026 at 7:02 p.m. CEST.
ad-hoc-news.de, 20.10.26 19:06 Uhr
Biogen Inc., US09062X1037
JPMorgan lifts target for Biogen stock to USD 300.00
Biogen's next earnings date is October 28, 2026. Biogen stock costs EUR 208.30 on October 16, 2026, plus 0.58 percent versus the Tradegate close.
ad-hoc-news.de, 17.10.26 20:31 Uhr
Biogen Inc., US09062X1037
JPMorgan lifts target to USD 300.00 for Biogen stock
Results are due October 28, 2026. Biogen stock costs EUR 211.05 on October 15, 2026, up 2.38 percent versus the Tradegate close of October 14, 2026.
ad-hoc-news.de, 15.10.26 20:35 Uhr
Biogen Inc., US09062X1037
Biogen presents lupus data: Biogen stock loses 2.06 percent ...
Litifilimab reached 27.20 percent clear skin at week 52, up from 19.00 percent at week 24. Biogen stock costs EUR 194.17 versus EUR 198.25 on October 8, 2026.
ad-hoc-news.de, 08.10.26 21:04 Uhr
Biogen Inc., US09062X1037
Biogen stock heads toward October 28 results after 1.69 ...
Biogen's Q2 revenue reached USD 2.736 billion after 3.4 percent year-over-year growth while GAAP EPS fell to USD 0.66. Jefferies sees Q3 EPS at USD 2.14 versus USD 2.07 consensus. ...
ad-hoc-news.de, 07.10.26 00:16 Uhr
Biogen Inc., US09062X1037
Biogen reports lupus data while Biogen stock trades at EUR ...
